O'Shaughnessy Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.7M | Sell |
18,418
-7,736
| -30% | -$4.34M | 0.04% | 396 |
|
|
2026
Q1 | $14.7M | Buy |
26,154
+482
| +2% | +$309K | 0.07% | 295 |
|
|
2025
Q4 | $17.4M | Buy |
25,672
+3,685
| +17% | +$2.51M | 0.1% | 232 |
|
|
2025
Q3 | $14M | Buy |
21,987
+11,813
| +116% | +$7.17M | 0.08% | 267 |
|
|
2025
Q2 | $5.46M | Buy |
10,174
+1,297
| +15% | +$620K | 0.04% | 446 |
|
|
2025
Q1 | $3.73M | Buy |
8,877
+2,281
| +35% | +$990K | 0.03% | 506 |
|
|
2024
Q4 | $2.73M | Sell |
6,596
-577
| -8% | -$253K | 0.02% | 562 |
|
|
2024
Q3 | $3.43M | Sell |
7,173
-165
| -2% | -$80.2K | 0.03% | 494 |
|
|
2024
Q2 | $3.58M | Buy |
7,338
+462
| +7% | +$232K | 0.04% | 443 |
|
|
2024
Q1 | $3.71M | Buy |
6,876
+639
| +10% | +$349K | 0.04% | 414 |
|
|
2023
Q4 | $3.46M | Sell |
6,237
-25
| -0.4% | -$11.7K | 0.05% | 391 |
|
|
2023
Q3 | $2.74M | Buy |
6,262
+876
| +16% | +$437K | 0.04% | 407 |
|
|
2023
Q2 | $2.71M | Buy |
5,386
+541
| +11% | +$259K | 0.04% | 390 |
|
|
2023
Q1 | $2.42M | Buy |
4,845
+565
| +13% | +$270K | 0.04% | 407 |
|
|
2022
Q4 | $1.75M | Buy |
4,280
+136
| +3% | +$52.8K | 0.03% | 459 |
|
|
2022
Q3 | $1.35M | Sell |
4,144
-4,124
| -50% | -$1.51M | 0.03% | 482 |
|
|
2022
Q2 | $2.9M | Sell |
8,268
-2,925
| -26% | -$1.19M | 0.05% | 311 |
|
|
2022
Q1 | $6.12M | Sell |
11,193
-708
| -6% | -$372K | 0.1% | 217 |
|
|
2021
Q4 | $7.84M | Buy |
11,901
+371
| +3% | +$233K | 0.14% | 172 |
|
|
2021
Q3 | $7.17M | Buy |
11,530
+2,582
| +29% | +$1.73M | 0.15% | 145 |
|
|
2021
Q2 | $5.65M | Buy |
8,948
+558
| +7% | +$308K | 0.11% | 171 |
|
|
2021
Q1 | $4.11M | Buy |
8,390
+2,286
| +37% | +$1.15M | 0.09% | 178 |
|
|
2020
Q4 | $3.05M | Buy |
6,104
+3,484
| +133% | +$1.56M | 0.08% | 160 |
|
|
2020
Q3 | $1.03M | Buy |
2,620
+2,380
| +992% | +$880K | 0.03% | 290 |
|
|
2020
Q2 | $79K | Buy |
240
+235
| +4,700% | +$68K | ﹤0.01% | 905 |
|
|
2020
Q1 | $1K | Sell |
5
-95
| -95% | -$24.8K | ﹤0.01% | 1221 |
|
|
2019
Q4 | $26K | Buy |
+100
| New | +$26.4K | ﹤0.01% | 1088 |
|
|
2019
Q3 | – | Sell |
-9,945
| Closed | -$2.74M | – | 1103 |
|
|
2019
Q2 | $2.74M | Sell |
9,945
-8,226
| -45% | -$2.03M | 0.06% | 158 |
|
|
2019
Q1 | $4.06M | Sell |
18,171
-96
| -0.5% | -$19.8K | 0.1% | 127 |
|
|
2018
Q4 | $3.4M | Sell |
18,267
-1,544
| -8% | -$317K | 0.09% | 141 |
|
|
2018
Q3 | $4.95M | Buy |
19,811
+3,734
| +23% | +$906K | 0.1% | 129 |
|
|
2018
Q2 | $3.5M | Sell |
16,077
-25,054
| -61% | -$5.16M | 0.07% | 155 |
|
|
2018
Q1 | $7.87M | Sell |
41,131
-19,901
| -33% | -$3.67M | 0.17% | 98 |
|
|
2017
Q4 | $9.54M | Sell |
61,032
-17,740
| -23% | -$2.79M | 0.22% | 80 |
|
|
2017
Q3 | $12.2M | Sell |
78,772
-7,428
| -9% | -$1.17M | 0.29% | 72 |
|
|
2017
Q2 | $13.9M | Buy |
86,200
+35,195
| +69% | +$5.72M | 0.33% | 65 |
|
|
2017
Q1 | $7.89M | Buy |
51,005
+22,240
| +77% | +$3.07M | 0.19% | 85 |
|
|
2016
Q4 | $3.37M | Buy |
28,765
+19,734
| +219% | +$2.25M | 0.08% | 152 |
|
|
2016
Q3 | $1.02M | Buy |
+9,031
| New | +$952K | 0.02% | 267 |
|
|
2016
Q1 | – | Sell |
-337
| Closed | -$25K | – | 971 |
|
|
2015
Q4 | $25K | Sell |
337
-137
| -29% | -$9.77K | ﹤0.01% | 649 |
|
|
2015
Q3 | $35K | Hold |
474
| – | – | ﹤0.01% | 607 |
|
|
2015
Q2 | $30K | Hold |
474
| – | – | ﹤0.01% | 650 |
|
|
2015
Q1 | $37K | Buy |
+474
| New | +$36.9K | ﹤0.01% | 627 |
|
|
2014
Q2 | – | Sell |
-96
| Closed | -$6K | – | 1003 |
|
|
2014
Q1 | $6K | Buy |
+96
| New | +$5.72K | ﹤0.01% | 812 |
|
Other funds holding IDXX
O'Shaughnessy Asset Management's IDXX Position: Q2 2026 in Review
O'Shaughnessy Asset Management reduced its Idexx Laboratories (IDXX) stake by 30% in Q2 2026, selling an estimated $4.34M and leaving 18,418 shares worth $9.7M. The position accounts for 0.04% of the portfolio, ranked #396.
O'Shaughnessy Asset Management first reported a position in IDXX in Q1 2014 and has held it in 44 quarters since. The position peaked at $17.4M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- O'Shaughnessy Asset Management held 18,418 shares of Idexx Laboratories worth $9.7M as of Q2 2026.
- O'Shaughnessy Asset Management sold 7,736 Idexx Laboratories shares in Q2 2026, an estimated $4.34M.
- Idexx Laboratories made up 0.04% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #396 holding.
- O'Shaughnessy Asset Management first reported a position in Idexx Laboratories in Q1 2014 and has held it in 44 quarters since.
- O'Shaughnessy Asset Management's Idexx Laboratories position peaked at $17.4M in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.